ATLANTA, July 29, 2010 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) ("Alimera"), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it will release its second quarter 2010 financial results after the market close on Thursday, August 12, 2010. An investor conference call will follow on the same day at 4:30 p.m. ET.